Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma-Reference-Cited by-同舟云学术

Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma

Published:2017-08-01 Issue:3 Volume:80 Page:623-629
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Gordeyev Sergey S.^ORCID,Rasulov Arsen O.,Gorbounova Vera A.,Tkachev Sergey I.,Glebovskaya Valeriya V.,Fedyanin Mikhail Yu.^ORCID,Besova Nataliya S.,Surayeva Yulia E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3408-4/fulltext.html

Reference35 articles.

1. Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354–356

2. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348(9034):1049–1054

3. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol Off J Am Soc Clin Oncol 15(5):2040–2049

4. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol Off J Am Soc Clin Oncol 14(9):2527–2539

5. James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol 14(6):516–524. doi: 10.1016/S1470-2045(13)70086-X

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies;Current Treatment Options in Oncology;2022-06-06

2. Advances of Nanomedicine in Radiotherapy;Pharmaceutics;2021-10-21

3. Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study;Cancer Medicine;2021-05

4. role of telehealth services in the treatment of rare disease: analysis of 1 year of work on the example of anal cancer;Pelvic Surgery and Oncology;2020-08-29

5. Anal squamous cell carcinoma – State of the art management and future perspectives;Cancer Treatment Reviews;2018-04